Global Tissue Diagnostics Market 2021

January 2022 | 14 pages | ID: G4A99F32B8ACEN
StrategyHelix Inc

Abstracts

The global tissue diagnostics market is poised to grow by US$ 1,698 million from 2021 to 2027, registering a CAGR of 6.2% during the forecast period, according to StrategyHelix. Rising geriatric population, rising incidence of cancer, developing infrastructure for cancer diagnosis, recommendation of cancer screening and availability of reimbursements are expected to boost the market growth in the coming years.

The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for tissue diagnostics. The global tissue diagnostics market is segmented on the basis of application, end user, and region. By application, the global tissue diagnostics market has been segmented into oncology, tissue typing, pathogen detection. According to the research, the oncology segment had the largest share in the global tissue diagnostics market. Based upon end user, the global tissue diagnostics market is categorized into research laboratories, others. In 2020, the research laboratories segment made up the largest share of revenue generated by the tissue diagnostics market. In terms of geography, the global tissue diagnostics market has been segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).

The global tissue diagnostics market is highly competitive. Some of the leading companies operating in the market are Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corporation (Beckman Coulter Inc.), F. Hoffmann-La Roche Ltd., GE Healthcare, Hologic Inc., Merck KGaA, Ortho Clinical Diagnostics Holdings plc, QIAGEN N.V., Siemens Healthineers AG, Thermo Fisher Scientific Inc.

Report Scope
Application: oncology, tissue typing, pathogen detection
End user: research laboratories, others
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2017 to 2027

Key Benefits for Stakeholders
Get a comprehensive picture of the global tissue diagnostics market
Pinpoint growth sectors and trends for investment

Contents

PART 1. INTRODUCTION

Scope of the study
Study period
Geographical scope
Research methodology

PART 2. TISSUE DIAGNOSTICS MARKET OVERVIEW

PART 3. MARKET BREAKDOWN BY APPLICATION

Oncology
Tissue typing
Pathogen detection

PART 4. MARKET BREAKDOWN BY END USER

Research laboratories
Others

PART 5. MARKET BREAKDOWN BY REGION

North America
Asia Pacific
Europe
Rest of the World (ROW)

PART 6. KEY COMPANIES

Abbott Laboratories
Agilent Technologies Inc.
Becton, Dickinson, and Company
bioMerieux SA
Bio-Rad Laboratories, Inc.
Danaher Corporation (Beckman Coulter Inc.)
F. Hoffmann-La Roche Ltd.
GE Healthcare
Hologic, Inc.
Merck KGaA
Ortho Clinical Diagnostics Holdings plc
QIAGEN N.V.
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
About StrategyHelix
Disclaimer